Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Irisin and betatrophin levels change differently in PCOS, which may help assess metabolic risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.

Age is more important than BMI for IVF success in women with infertility and PCOS.

PCOS may increase eye pressure and corneal thickness, affecting eye health.

Smaller reticle sizes are as accurate as the standard size for measuring hair density in hair restoration.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.